Hemato- Immunology & Stem Cell Research

Blood group are of ABO sort and however at introduce the Rh blood gathering of 50 very much characterized antigens in which 5 are more vital they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in anticipation of erythroblast fetalis lacking of Rh antigen it characterized as negative and existences of Rh antigen in blood prompts positive these prompts rh inconsistency. The prevention treatment of illnesses identified with the blood is called as the Hematology. The haematologists conduct a work at cancer to. The disorder of immune system leading to the hypersensitivity is called as Clinical Immunology and the abnormal development of a disease are known as Inflammation and the emerge of an abnormal immune reaction to the body or an immune suppression are known as Auto immune disorder. The undifferentiated cell treatment is utilized to treat or keep an illness or a condition for the mostly Bone marrow undifferentiated cell treatment is seen and as of late umbilical cord treatment Stem cell transplantation methodologies remains an unsafe system with many possible confusions; it is saved for patients with life-threatening sicknesses.

  • Blood Groups and Rh Incompatibility
  • Hematology and Clinical Immunology
  • Immunology of Blood Cancer
  • Inflammatory/Autoimmune Diseases
  • Bone Marrow Stem Cell Therapy
  • Stem Cell Transplantation Strategies

Related Conference of Hemato- Immunology & Stem Cell Research

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Hemato- Immunology & Stem Cell Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in